QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.107.039354v1 73/2/451    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Onica, T. Articles by Kirby, G. M. Search for Related Content PubMed PubMed Citation Articles by Onica, T. Articles by Kirby, G. M.

Dexamethasone-Mediated Up-Regulation of Human CYP2A6 Involves the Glucocorticoid Receptor and Increased Binding of Hepatic Nuclear Factor 4 to the Proximal Promoter

Department of Biomedical Sciences, University of Guelph, Guelph, Ontario, Canada (T.O., K.N., M.L., L.N., A.M., G.M.K.); Institut National de la Santé et de la Recherche Médicale U632, Montpellier, France, and Univ Montpellier1, Montpellier, France (J.-M.P., M.-J.V., P.M.); and Institute of Medical Chemistry and Biochemistry, Faculty of Medicine, Palacky University, Olomouc, Czech Republic (Z.D.)

Human cytochrome P450 2A6 (CYP2A6) metabolizes various clinically relevant compounds, including nicotine- and tobacco-specific procarcinogens; however, transcriptional regulation of this gene is poorly understood. We investigated the role of the glucocorticoid receptor (GR) in transcriptional regulation of CYP2A6. Dexamethasone (DEX) increased CYP2A6 mRNA and protein levels in human hepatocytes in primary culture. This effect was attenuated by the GR receptor antagonist mifepristone (RU486; 17β-hydroxy-11β-[4-dimethylamino phenyl]-17-[1-propynyl]estra-4,9-dien-3-one), suggesting that induction of CYP2A6 by DEX was mediated by the GR. In gene reporter assays, DEX caused dose-dependent increases in luciferase activity that was also prevented by RU486 and progressive truncations of the CYP2A6 promoter delineated DEX-responsiveness to a -95 to +12 region containing an hepatic nuclear factor 4 (HNF4) response element (HNF4-RE). Mutation of the HNF4-RE abrogated HNF4- and DEX-mediated transactivation of CYP2A6. In addition, overexpression of HNF4 increased CYP2A6 transcriptional activity by 3-fold. DEX increased HNF4 mRNA levels by 4-fold; however, the amount of HNF4 nuclear protein was unaltered. Electrophoretic mobility shift, chromatin immunoprecipitation (ChIP), and streptavidin DNA binding assays revealed that DEX increased binding of HNF4 to the HNF4-RE and that an interaction of GR and HNF4 occurred at this site. Moreover, ChIP assays indicated that histone H4 acetylation of the CYP2A6 proximal promoter chromatin was increased by DEX that may allow for increased binding of HNF4 to the HNF4-RE in human hepatocytes. These findings indicate that increased expression of CYP2A6 by DEX is mediated by the GR via a nonconventional transcriptional mechanism involving interaction of HNF4 with an HNF4-RE rather than a glucocorticoid response element.

Received for publication July 12, 2007.

Accepted for publication October 31, 2007.

Address correspondence to: Dr. Gordon M. Kirby, Department of Biomedical Sciences, University of Guelph, Guelph, ON, Canada, N1G 2W1. E-mail: gkirby{at}uoguelph.ca

This article has been cited by other articles:

				N. Anderson and J. Borlak Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357. [Abstract] [Full Text] [PDF]